Cycles triggered with GnRH agonist: exploring low-dose HCG for luteal support J.C. Castillo, M. Dolz, E. Bienvenido, L. Abad, E.M. Casañ, F. Bonilla-Musoles Reproductive BioMedicine Online Volume 20, Issue 2, Pages 175-181 (February 2010) DOI: 10.1016/j.rbmo.2009.11.018 Copyright © 2009 Reproductive Healthcare Ltd. Terms and Conditions
Figure 1 Treatment protocol and luteal-phase supplementation scheme. Recombinant FSH (rFSH; 150–200IU) was used for stimulation. Gonadotrophin-releasing hormone antagonist (0.25mg/day) started when follicles reached ⩾14mm. Ovulation was triggered with leuprolide acetate (1.5mg). Luteal phase was supported with three doses of human chorionic gonadotrophin (HCG; 250–1000IU). Reproductive BioMedicine Online 2010 20, 175-181DOI: (10.1016/j.rbmo.2009.11.018) Copyright © 2009 Reproductive Healthcare Ltd. Terms and Conditions